Roivant Sciences Ltd WT (ROIVW)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ROIVW | CNSP | BDRX | ||
| Company | Roivant Sciences Ltd WT | Cns Pharmaceuticals Inc | Biodexa Pharmaceuticals Plc ADR | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 2.86 | 2.51 | 3.52 | ||
| High | 2.92 | 2.60 | 4.38 | ||
| Low | 2.75 | 2.37 | 3.50 | ||
| Latest | 2.75 | 2.43 | 4.26 | ||
| Change | -0.11 | -0.11 | +0.78 | ||
| % Change | -3.85% | -4.33% | +22.41% | ||
| Volume | 37,800 | 2,932 | 139,397 | ||
| 20-Day Average Volume | 201,870 | 35,924 | 1,320,519 | ||
| Previous Close | 2.86 | 2.54 | 3.48 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | No | No | ||
| Technicals | |||||
| 20-Day Moving Average | 2.78 | 2.43 | 3.44 | ||
| 20-Day Raw Stochastic | 39.13% | 36.17% | 37.98% | ||
| 20-Day Relative Strength | 49.75 | 41.05 | 47.69 | ||
| Weighted Alpha | +210.22 | -82.77 | -94.48 | ||
| Today's Opinion | 48% Buy | 96% Sell | 80% Sell | ||
| Previous Opinion | 96% Buy | 80% Sell | 88% Sell | ||
| Last Month's Opinion | 88% Buy | 100% Sell | 100% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +1.10% since 08/25/23 | -4.38% since 04/13/26 | +39.92% since 04/13/26 | ||
| Low | 2.75 on 09/01/23 | 2.38 on 04/14/26 | 3.03 on 04/14/26 | ||
| High | 2.93 on 08/31/23 | 2.89 on 04/15/26 | 4.38 on 04/20/26 | ||
| 1-Month | |||||
| %Chg | -15.12% since 08/01/23 | +4.80% since 03/20/26 | +23.82% since 03/20/26 | ||
| Low | 2.57 on 08/17/23 | 2.06 on 04/09/26 | 2.86 on 04/13/26 | ||
| High | 3.21 on 08/02/23 | 3.00 on 03/25/26 | 6.75 on 04/02/26 | ||
| 3-Month | |||||
| %Chg | +30.95% since 06/01/23 | -66.99% since 01/20/26 | -60.75% since 01/20/26 | ||
| Low | 1.92 on 06/27/23 | 2.06 on 03/18/26 | 2.86 on 04/13/26 | ||
| High | 4.00 on 07/06/23 | 7.42 on 01/21/26 | 11.35 on 01/26/26 | ||
| 6-Month | |||||
| %Chg | +59.88% since 03/01/23 | -73.77% since 10/20/25 | -88.45% since 10/20/25 | ||
| Low | 1.23 on 03/23/23 | 2.06 on 03/18/26 | 2.86 on 04/13/26 | ||
| High | 4.00 on 07/06/23 | 9.14 on 10/21/25 | 44.70 on 12/10/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | N/A | 2,061 | 475 | ||
| Shares Outstanding, K | N/A | 811 | 136 | ||
| Annual Sales | 29,050,000 | 0 | 0 | ||
| Annual Net Income | -171,980,000 | -15,850,000 | -8,420,000 | ||
| Last Quarter Sales | 1,999,000 | 0 | N/A | ||
| Last Quarter Net Income | -265,891,000 | -5,960,000 | N/A | ||
| 60-Month Beta | N/A | 2.74 | 1.11 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | -10.15 on 03/31/26 | N/A | ||
| Latest Earnings Date | 06/04/26 | 05/21/26 | 06/26/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | N/A | 0.00 | 0.00 | ||